Align Technology posts stronger year-to-date growth despite softer quarterly profitability

Bottom line

Align Technology, Inc. filed a Form identified by the 10-Q key covering the three-month reporting period the three months ended June 30, 2026 and the six-month year-to-date period the six months ended June 30, 2026, filed under accession 0001097149-26-000060 for issuer 0001097149 (ticker ALGN), and the headline bottom-line reading is mixed across the two windows. For the three-month period, Revenue from Contract with Customer, Excluding Assessed Tax printed at $1,056,192,000 USD against $1,012,449,000 USD — a reported increase on the top line — yet both Net Income (Loss) Attributable to Parent ($108,294,000 USD versus $124,608,000 USD) and Operating Income (Loss) ($154,013,000 USD versus $163,033,000 USD) carry a reported decrease on the quarter, with Earnings Per Share, Diluted ($1.51 per diluted share USD/SHARES versus $1.72 per diluted share USD/SHARES) likewise showing a reported decrease; each remains in profit-to-profit territory. The six-month window tells the opposite story: Revenue ($2,096,279,000 USD versus $1,991,711,000 USD), Operating Income (Loss) ($295,968,000 USD versus $294,133,000 USD), Net Income (Loss) Attributable to Parent ($221,065,000 USD versus $217,838,000 USD), and Earnings Per Share, Diluted ($3.09 per diluted share USD/SHARES versus $2.98 per diluted share USD/SHARES) are all reported increases, again staying within a profit-to-profit transition. The unaudited Condensed Consolidated Financial Statements are prepared on a basis consistent with the prior-year audited statements per Note 1, and the filing references trademark schedules at Item 6 and Item 5 alongside the controls discussion at Item 4 and Item 3; risk and legal coverage sits at Item 1A and Item 1.

The filing evidence does not attribute this change to any single cause.

No independent inference is offered beyond the reported directions above; the six-month figures trending higher while the three-month figures step lower is the visible shape of the report, and whether the quarter softness is a timing effect, a cost item, or a mix issue is left to later sections of this analysis.

None within the filing evidence base for this section.

Peer or industry comparators are not in scope here, so The filing evidence contains no peer or industry comparison.; segment-level drivers behind the quarter-versus-six-month divergence are also not addressed in this opening section.

Financial performance

- $1,012,449,000 USD in the prior-year the three months ended June 30, 2025 to $1,056,192,000 USD in the current the three months ended June 30, 2026, an authorized higher revenue read on the year-over-year three-month window; the period remained a profit from contract revenue with customers, excluding assessed tax, in both halves of the comparison. - On the half-year window, the same revenue line ran from $1,991,711,000 USD in the six months ended June 30, 2025 to $2,096,279,000 USD in the six months ended June 30, 2026, again an authorized higher direction, holding the franchise at a profit in both reporting stretches.

- Operating profitability moved in the opposite direction on the quarter: $163,033,000 USD in the prior-year quarter shifted to $154,013,000 USD in the current quarter, an authorized lower quarter result while staying a profit rather than a loss. - On the year-to-date view, operating profit ran from $294,133,000 USD in the half-year comparative to $295,968,000 USD in the current half-year, an authorized higher operating-profit read with no transition in or out of profitability. - Bottom-line earnings on the quarter slipped from $124,608,000 USD in the three months ended June 30, 2025 to $108,294,000 USD in the current quarter, again an authorized lower direction while preserving the profit-to-profit transition; on the half-year view, net income moved from $217,838,000 USD to $221,065,000 USD, an authorized higher path with the same profit-to-profit transition.

72 per diluted share USD/SHARES in the prior quarter vs. 98 per diluted share USD/SHARES in the six months ended June 30, 2025 vs. 09 per diluted share USD/SHARES in the six months ended June 30, 2026 (authorized higher, profit-to-profit).

- The filing evidence does not attribute this change to any single cause. - Accounting context sits in Note 1 and the disclosure paragraph on estimates: the filing reminds readers that "we base our estimates on historical experience and on various other assumptions that are believed to be reasonable," a posture that matters for the disclosed sensitivity of carrying values, useful-life revisions tied to planned disposals per Note 14, and the inventory composition shown in Note 3. - Recent guidance from standard-setters is summarized in the same narrative block: the Company adopted the credit-losses practical expedient referenced through Note 1 and noted it "did not have a material impact on the financial statements," while the derivatives/hedging, internal-use software, and expense-disaggregation updates remain under evaluation with no expected balance-sheet or statement-of-operations impact at adoption.

- Concentration of credit risk is concentrated in cash and cash equivalents held in bank accounts that "exceed federally insured FDIC limits," and supply concentration is flagged as a future-results risk if a manufacturer or supplier cannot fulfill requirements. - Fair-value hierarchy is mapped under Level 1 through Level 3, with the latter covering unobservable inputs for assets or liabilities. - The filing evidence contains no peer or industry comparison.

- Forward outlook is not quantified in the filing evidence; readers seeking directional cross-checks can compare the higher half-year revenue and net-income moves against recent peers like REINSURANCE GROUP OF AMERICA INC Posts Higher Revenue and Net Income in Filing rather than against any in-text guidance.

Operating drivers and segments

- The issuer's product portfolio discussed in the narrative is anchored on the Invisalign and iTero brands, with the cited trademark passage pointing to a single company-level reporting construct rather than separately disclosed operating segments. - Revenue from Contract with Customer, Excluding Assessed Tax is shown for the three-month reporting period and for the six-month year-to-date period, and the comparable prior-year lines are also presented; together those four figures constitute the operating evidence available at the income-statement level for ALIGN TECHNOLOGY INC. - Operating Income (Loss) is likewise shown for the three-month reporting period and the six-month year-to-date period, alongside the matching prior-year comparatives, giving a two-window view of operating profitability at the company level. - Authorized direction changes for the revenue and operating-income lines describe a higher six-month year-to-date revenue base against the prior-year comparative, a higher three-month revenue against the prior-year quarter, a higher six-month operating result against the prior-year comparative, and a lower three-month operating result against the prior-year quarter — a pattern of full-year improvement with a softer most-recent quarter. - No segment revenue, segment cost, or geographic split is presented in the filing evidence for this 10-Q period-ended-2026-06-30 filing, so segment-level drivers cannot be parsed from the supplied material.

- Management's prepared commentary in the quoted narrative is limited to accounting-policy and basis-of-presentation language, the trademark enumeration, and a description of the disposal-date revision to useful lives of certain assets disclosed under Note 14, the restructuring-related note. - Management does not, in the quoted material, attribute the period-over-period movement in revenue or operating income to any specific operational driver, and it explicitly cautions that the results for the three and six months are not necessarily indicative of the full year ending December of the reporting cycle. - Recent Accounting Pronouncements, both adopted and not-yet-effective, are described at a procedural level, with management stating that adoption of the recently adopted standard did not have a material impact and that the pending standard is not expected to have a material effect on consolidated financial position or results of operations. - Because the quoted narrative does not connect a named driver to the revenue or operating-income movements, any reader-facing causal statement would be unsupported. The filing evidence does not attribute this change to any single cause. - The filing evidence contains no peer or industry comparison. The filing evidence contains no peer or industry comparison. - Readers seeking a cross-issuer contrast on a higher-revenue, higher-net-income interim print can weigh the separately written REINSURANCE GROUP OF AMERICA INC Posts Higher Revenue and Net Income in period-ended-2026-06-30 Filing against this ALIGN TECHNOLOGY INC filing, since the two reports share the period orientation but differ on segment and product disclosures.

Cash flow and capital

- Cash and cash equivalents, at carrying value, stood at $1,102,591,000 as of the balance sheet date (the balance sheet date of June 30, 2026), framing the liquidity backdrop against which the period's three cash-flow streams need to be read. - Net cash provided by operating activities was $343,799,000 for the six-month year-to-date period (the six months ended June 30, 2026), compared with $181,326,000 for the prior-year comparative (the six months ended June 30, 2025); the authorized direction is an increase, with both periods showing positive operating cash generation.

- Net cash used in investing activities was -$213,738,000 for the six-month year-to-date period (the six months ended June 30, 2026), versus -$56,768,000 for the prior-year comparative (the six months ended June 30, 2025); the authorized direction is a decrease (a larger outflow than the prior year), with both periods showing a negative investing figure. - Net cash used in financing activities was -$115,575,000 for the six-month year-to-date period (the six months ended June 30, 2026), against -$303,055,000 for the prior-year comparative (the six months ended June 30, 2025); the authorized direction is an increase (a smaller outflow than the prior year), with both periods showing negative financing flows.

- Within the investing outflow, payments to acquire property, plant, and equipment were $66,450,000 for the six-month year-to-date period (the six months ended June 30, 2026), compared with $46,768,000 for the prior-year comparative (the six months ended June 30, 2025); the authorized direction is an increase, with both periods showing positive capital spending. - Within the financing outflow, payments for repurchase of common stock were $98,126,000 for the six-month year-to-date period (the six months ended June 30, 2026), versus $297,134,000 for the prior-year comparative (the six months ended June 30, 2025); the authorized direction is a decrease (smaller buyback outflows than the prior year), with both periods showing positive cash returned through repurchases.

- On the working-capital side of the balance sheet at the balance sheet date of June 30, 2026, accounts receivable, after the allowance for credit loss, were $1,148,392,000 and accounts payable, current, were $109,841,000, together with the cash position already cited; the filing also describes an accounts-receivable factoring program (control over transferred receivables surrendered, cash proceeds included in operating cash flows, factoring fees recorded in other income (expense), net and described as not material), providing context for how receivables are monetized without sitting on the balance sheet.

- The convertible-notes disclosure locates the related fair-value estimate within Level 3 of the GAAP fair value hierarchy because one or more significant inputs are unobservable, while foreign currency forward contracts are classified within Level 2 using observable market-based inputs, including foreign currency spot and forward rates; the investments in privately held companies are accounted for under the measurement alternative (cost minus impairment, plus adjustments for observable transactions), with the equity-method investments carried at fair value and reported within other assets.

- The filing evidence does not attribute this change to any single cause. - The cash-flow, capital-allocation, and working-capital picture above is drawn solely from the six-month year-to-date and balance-sheet evidence cited; no quarterly cash-flow detail, debt-issuance schedule, dividend record, or segment-level capital allocation is included in this filing's filing evidence, and the filing does not contain peer or industry cash-conversion or buyback-intensity comparisons. The filing evidence contains no peer or industry comparison.

Peer and historical context

The filing for ALIGN TECHNOLOGY INC (ALGN) on 10-Q for period-ended-2026-06-30, accession 0001097149-26-000060, frames all comparison only against its own prior-year windows; the filing does not benchmark the issuer against any named competitor, index, or industry cohort, so peer-side context has to be sourced from outside this document or left unsaid.

On the year-to-date window, Revenue from Contract with Customer, Excluding Assessed Tax rose year over year, comparing the six-month period against the prior-year six months. Operating Income (Loss) also moved higher on the same comparison, with the current period and the prior-year six months both profitable. Net Income (Loss) Attributable to Parent likewise expanded year over year on the six-month comparison, again a profit-to-profit transition. Net Cash Provided by (Used in) Operating Activities was higher on the six-month comparison than in the prior-year six months, while Earnings Per Share, Diluted on the same window was higher year over year on a profit-to-profit basis.

The three-month comparison tells a more mixed story. Revenue from Contract with Customer, Excluding Assessed Tax still rose year over year for the quarter against the prior-year quarter. However, Operating Income (Loss) and Net Income (Loss) Attributable to Parent both narrowed year over year on the three-month comparison, each transitioning profit to profit but at a lower level. Earnings Per Share, Diluted on the quarter comparison likewise was lower year over year, again profit to profit. The half-year expansion paired with a quarter-on-quarter deceleration is consistent with growth concentrated earlier in the year and softer sequential momentum, though the filing does not state this directly. The filing evidence does not attribute this change to any single cause.

Capital-allocation signals from the cash flow statement also move in opposing directions on the six-month comparison. Payments to Acquire Property, Plant, and Equipment were higher year over year for the six months than in the prior-year six months. Payments for Repurchase of Common Stock were lower on the same comparison. Net Cash Provided by (Used in) Investing Activities was a smaller negative year over year on the half-year window, while Net Cash Provided by (Used in) Financing Activities was a larger negative. None of these directional moves are tied by the filing to any specific driver. The filing evidence does not attribute this change to any single cause.

The filing references risk-factor disclosures carried forward from the Annual Report on Form referenced in Item 8, but it does not restate operating-segment or geographic peers, nor does it name any competitor for benchmarking, so no direct peer comparison is available within this filing. The filing evidence contains no peer or industry comparison.

For a sense of how a peer-style headline can read across filers, the Lizely Finance Earnings Analysis — UFP TECHNOLOGIES INC Interim Filing: Profit-to-Profit Growth on Both Windows write-up applies a similar half-year-versus-quarter lens, and the REINSURANCE GROUP OF AMERICA INC Posts Higher Revenue and Net Income in Filing piece shows another profit-to-profit half-year pattern.

- Revenue, six months: $2,096,279,000 vs. $1,991,711,000; higher year over year - Revenue, quarter: $1,056,192,000 vs. $1,012,449,000; higher year over year - Operating Income, six months: $295,968,000 vs. $294,133,000; higher year over year, profit to profit - Operating Income, quarter: $154,013,000 vs. $163,033,000; lower year over year, profit to profit - Net Income, six months: $221,065,000 vs. $217,838,000; higher year over year, profit to profit - Net Income, quarter: $108,294,000 vs. $124,608,000; lower year over year, profit to profit - Operating Cash Flow, six months: $343,799,000 vs. $181,326,000; higher year over year

Scenario analysis

- Reported facts anchor this scenario set on the three-month and six-month year-to-date performance windows for ALIGN TECHNOLOGY INC in its period-ended-2026-06-30 filing under 10-Q (accession 0001097149-26-000060, CIK 0001097149, ticker ALGN). Revenue from Contract with Customer, Excluding Assessed Tax for the three-month period the three months ended June 30, 2026 stood at $1,056,192,000, and for the six-month window the six months ended June 30, 2026 it stood at $2,096,279,000. The prior-year comparatives were $1,012,449,000 for the three months ended June 30, 2025 and $1,991,711,000 for the six months ended June 30, 2025.

The authorized direction in both windows is higher than the prior period. - Net Income (Loss) Attributable to Parent was $108,294,000 for the three months ended June 30, 2026 versus $124,608,000 for the three months ended June 30, 2025, with an authorized direction that is lower than the prior period. Across the year-to-date window, net income was $221,065,000 for the six months ended June 30, 2026 versus $217,838,000 for the six months ended June 30, 2025, with an authorized direction that is higher than the prior period.

Each transition stays within a profit-to-profit framing. - Management explanation in the filing is limited to the balance-sheet mechanics shown in the cited notes: goodwill activity is captured at Note 4, balance-sheet components at Note 3, financial-instrument fair-value inputs at Note 2 with the foreign-currency forwards classified within Level 2, and stockholders' equity disclosures at Note 7 and Note 6. Equity-method investments in Heartland and Smile Doctors are described in narrative terms without numeric anchors that the catalog exposes to this section.

- Analyst inference must therefore be narrow. Revenue moving higher than the prior period on both windows, while net income moves lower than the prior period on the three-month window and higher than the prior period on the year-to-date window, is the only directional fact this scenario set can lean on. Everything beyond it is structural context from Item 1A risk factors, Item 4 controls and procedures, and the goodwill and intangible carrying-value discussion in Note 4.

The filing evidence does not attribute this change to any single cause. - Counter-evidence inside the filing cuts both ways. The revenue trend is unambiguously higher than the prior period on both windows, which underwrites a constructive read.

The three-month net-income direction is lower than the prior period, which tempers the upside. Restructuring context referenced in Note 14 and the equity-method disclosures indicate the quarter-to-quarter bottom line carries one-off character that the year-to-date window smooths out, though no causal weight is asserted here. ), and the catalog does not expose operating-income, cash-flow, or share-repurchase values to this section, so any scenario that depends on those levers must remain qualitative.

- Scenario framing. The base case treats the higher-than-prior-period revenue on both windows as the durable signal and the lower-than-prior-period three-month net income as a temporary quarter-specific reading. The upside case requires the year-to-date higher-than-prior-period net income to extend and the three-month reading to reverse in subsequent reporting.

The downside case assumes the three-month lower-than-prior-period net income persists while revenue continues to print higher than the prior period, compressing profitability even as the top line grows. Investors comparing similar quarter-versus-prior-period reversals across filings can review REINSURANCE GROUP OF AMERICA INC Posts Higher Revenue and Net Income in Filing for a contrasting same-direction pattern.

Risks and what to watch

- Reported facts: For the three-month reporting period, ALIGN TECHNOLOGY INC posted Revenue from Contract with Customer, Excluding Assessed Tax of $1,056,192,000 USD, higher than the prior-year comparative of $1,012,449,000 USD for the three months ended June 30, 2025. For the six-month year-to-date period, Revenue from Contract with Customer, Excluding Assessed Tax was $2,096,279,000 USD, higher than the prior-year comparative of $1,991,711,000 USD for the six months ended June 30, 2025. Net Income (Loss) Attributable to Parent was $108,294,000 USD for the three-month period, lower than the prior-year comparative of $124,608,000 USD, and $221,065,000 USD for the six-month period, higher than the prior-year comparative of $217,838,000 USD.

The divergence between top-line growth and the quarterly bottom-line contraction is the central risk tension of this filing. - Management explanations: The cited note in Note 2 describes the carrying value of investments in equity securities and equity method investments, with any price adjustments or impairment flowing through Other income (expense), net. The note also describes foreign currency forward contracts classified within Level 2 of the fair value hierarchy, with settlement gains and losses recorded in Other income (expense), net.

Both items sit outside revenue and outside core operating costs, so swings in these lines can separate earnings from revenue trajectory. - Analyst inference: With revenue up on both windows but net income down on the quarter and up on the half-year, the pattern is consistent with non-operating or below-the-line volatility moving net income in a different direction than top-line growth. The presence of equity method investments and FX forward contracts discussed in the cited note means fair-value remeasurements and currency settlement are plausible contributors, but the filing does not attribute the shift.

The filing evidence does not attribute this change to any single cause.. - Counter-evidence: The half-year bottom line is still higher year over year, which weighs against a uniform deterioration narrative. Revenue is higher on both windows, and goodwill is the only intangible category whose change is described over the six-month period in Note 4, with no impairment language appearing in the quoted material.

Substantially all remaining performance obligations relate to clear aligner contracts and system and services arrangements, per the cited note, so deferred revenue is the natural forward-looking offset. - Unknowns: The filing does not break out segment-level result detail for this dimension, so geographic, product, or channel mix is not visible here. The filing evidence does not disclose segment-level detail for this dimension..

The filing does not compare performance to any peer or industry benchmark. The filing evidence contains no peer or industry comparison.. The cause of the quarterly net income decline is not stated.

The filing evidence does not attribute this change to any single cause.. Legal proceedings under Item 1A and quantitative and qualitative disclosures under Item 3 are referenced but not elaborated in the quoted material, so their potential P&L impact is not quantifiable. - Metrics to watch next period: the relationship between revenue growth and net income, with attention to whether foreign currency forward settlement gains and losses, equity method investment remeasurement, and any goodwill movement under Note 4 continue to drive the wedge; the level of clear aligner and system and services deferred revenue, as performance obligations recognized; the legal-proceedings disclosure under Item 1A; and the controls and procedures update under Item 4.

Readers can place these alongside earnings comparisons such as REINSURANCE GROUP OF AMERICA INC Posts Higher Revenue and Net Income in Filing when benchmarking the next interim.